BioTechSnack (@SnackBioTech) header
BioTechSnack (@SnackBioTech) profile picture

it was always just an ode to the Hack.

Joined May 2018
Photo by BioTechSnack (@SnackBioTech)Photo by BioTechSnack (@SnackBioTech)Photo by BioTechSnack (@SnackBioTech)Photo by BioTechSnack (@SnackBioTech)Photo by BioTechSnack (@SnackBioTech)Photo by BioTechSnack (@SnackBioTech)Photo by BioTechSnack (@SnackBioTech)Photo by BioTechSnack (@SnackBioTech)Photo by BioTechSnack (@SnackBioTech)Photo by BioTechSnack (@SnackBioTech)
BioTechSnack retweeted
Frank Braconi, who is an actual economist, inadvertently asked me a softball question about why the operating expenses of non-profit housing owners are usually double those of for-profit owners. I also note that public housing operating expenses are usually triple those of private, for-profit owners. Amazingly, even with the orders of magnitude of additional spending, the non-profit buildings tend to have worse physical conditions and the public housing buildings are well known to be the worst of all. With apologies in advance that this post may be too technical and into the weeds for some, here we go. As Frank surely knows, there are these standard economic concepts called Principal Agent and Moral Hazard. Let's examine these in terms of the three kinds of housing ownership. In for-profit housing, the owner/manager is the Principal Agent and its motivation is the long term maximization of income and return on capital reinvestments. When it comes to "purchased items" this owner carefully negotiates and bids costs with suppliers, minimizes waste, avoids costly violations and fines, fears foreclosure and litigation and reserves capital to reinvest in well-planned component replacement and money saving innovations. Examples include heat timers, utility submetering and complex self-insurance structures, to key off Frank's questions below. Utility submetering, for one, reduces consumption by 2/3 in practice: a huge savings! There is very little Moral Hazard here because the Principal Agent is the direct beneficiary of the cost savings and it is not a judgment-proof entity. In non-profit housing, we encounter our first Moral Hazard. The owner is an entity that by virtue of being the owner of last-resort, has an soft loss backstop from the public. The non-profit's manager, acting as Principal Agent, still has to do all the work of a manager but is only compensated by a salary, also a hazard. So in the non-profit scenario, the manager will do everything to maximize its salary but only impose as much careful effort as is needed to prevent the building from literally collapsing. Since this type of property doesn't have to pay real estate taxes, an amount which usually would be around half of net income, all of that money can be squandered on careless and indifferent negotiation and purchasing with suppliers. It should surprise no one that careless purchasing often comes with emoluments for the Principal Agent, another Moral Hazard. This owner is also less risk averse, because when fines and violations arrive resulting in eventual litigation judgments, there is no owner to worry about the outcome. They become just another delayable payable. Conditions naturally deteriorate but at least the building doesn't fall over. And finally we have the public owner who truly has no "skin in the game." Perversely, the public owner cares mostly about how to MAXIMIZE the operating costs because the Principal Agent and Moral Hazard problems are here in full effect. The salary to manage public housing is a pittance, so the Principal Agent may only earn their fair compensation through emoluments. The legendary graft at agencies like NYCHA is well documented and consistent at public housing throughout the world. Moreover, prevailing wage regulations already force any operating expense that includes a service to cost at least double, even before any mischief takes place. Of recent note, the well publicized case of the NYCHA employee-plumber Jakub Markowski who allegedly earned $465k via overtime rigging. When the property earns fines and violations, develops truly dangerous conditions or employees behave with utter gross negligence, only the taxpayer is on the hook and no one ever loses their job or pension thanks to the representatiion of powerful labor syndicates. With this incentive structure, it should be no surprise at all that building conditions are atrocious and it costs $527k to renovate a single public housing unit.
Any idea why non-profit operating costs would be 2x that of for-profit owners? A lot of operating costs are just purchased items, like heating oil, water, electricity, insurance, etc.
89
282
65
2,081
264,202
BioTechSnack retweeted
$NVIDIA Su would never do something so Huang. $AMD
1
1
561
Just published in @BloodJournal our @FredHutch investigator-initiated trial of CD20 CAR T in Waldenström macroglobulinemia—the largest reported CAR T series in WM. Developed in Brian Till’s lab; I had the privilege of serving as PI. The joy of bringing science from lab to clinic! ashpublications.org/blood/ar…… @IWMF_WM
2
14
3
46
3,478
BioTechSnack retweeted
Re: Walleye
14
62
16
971
186,162
Looking for election results? We've made it easier to find what matters to you! Washington's updated election results website lets you filter, search, and follow contests so you can quickly find the results you want. Explore the site at results.votewa.gov.
7
36
3
152
19,335
#ESMO26 embargo lifted following breach. Detailed data confirm Moderna $MRNA and Merck $MRK cancer vaccine met key endpoints in melanoma trial Personalized mRNA therapy reduced disease recurrence by 42% compared to standard treatment statnews.com/2026/10/22/esmo…
19
39
8
247
414,931
BioTechSnack retweeted
$MRNA data leaked and looks very positive teapawt.net/pharmacreep/status/211…
$MRK $MRNA data amazing HR .58. So $MRK $MRNA data leaked to this website which is now down. HR is .58. oncology-central.com/interpa…
20
11
1
45
31,534
Last night at Syberjet (Trevor Milton’s Jet Startup) The wings were propped up by posts and not attached to the airplane.
75
14
18
769
116,882
Replying to @SnackBioTech
I was literally posting a pic. I am gonna go full out about how much of a shit show the presentation was
1
3
50
6,575
BioTechSnack retweeted
Takes time to know the good accounts from the bad ones, but it’s worth it
One month (or so) on @X , a platform unlike any other. Energy, speed, smarts and stupidity. -The best thing in BioX - Rapid and divergent takes on new clinical data, on balance usually right..wisdom of crowds -The worst thing on BioX - Shameless replies and reposts pumping your own book, praying for M&A about your favorite name, plane stalking…do people actually think this is how a real drug company or serious investor makes decisions? Maybe it just makes you feel like you have some agency, then ok.
1
2
25
3,416
The STAT family received some devastatingly sad news this morning. Helen Branswell, a beloved colleague and renowned infectious disease reporter, passed away. A beautiful tribute to Helen, written with love by our colleague @DrewQJoseph Helen will be greatly missed. statnews.com/2026/10/13/hele…
23
25
10
193
29,996
BioTechSnack retweeted
Replying to @Mtnjack68 @JoelVilu
Lenders have bot armies to trash talk any honest discussion.
1
1
5
404
BioTechSnack retweeted
Porte-parole de l'ONU  « Une enquête interne a conclu que des travailleurs humanitaires de l'UNRWA à Gaza ont "très probablement" participé au massacre perpétré par le Hamas le 7 octobre, qui a coûté la vie à 1 200 hommes, femmes et enfants israéliens !
433
6,274
631
13,210
595,694
BioTechSnack retweeted
Dostoyevsky on the death of his infant daughter. A passage that has stayed with me years after I first encountered it
330
18,341
749
206,638
4,212,996
BioTechSnack retweeted
They raised. Don’t short this stuff. $MRNA
Yes yes. A raise. Would be the best move. If they don’t then I’d go short $MRNA
1
1
3
2,343
BioTechSnack retweeted
I'm apparently live-tweeting the $GRAL panel if you want to follow along. It's an interesting one: What's the requirement to approve a blood test for multiple types of cancer?
I’m following the FDA advisory committee on $GRAL’s Galleri blood test for detecting multiple types of cancer today and will be posting my thoughts here. So far, we’ve seen only company presentations, usually the dullest part of an advisory panel. But there have been some interesting tidbits. First, Grail is leaning heavily into simply the idea that they detect more cancers and can localize them, not getting into larger questions about the benefit to patients from doing so. See this slide. Speaking as part of Grail’s presentation, Mylynda Massart, a family medicine at UPMC, argued that the test can fit will with existing cancer screening and is something that many patients are eager to use. The panelists, in their first questions, expressed skepticism. One asked if the incredible, white-glove treatment that Grail gives doctors now can really scale. Another responded a Grail comment: “You’re carefully choosing your words. It is curative intent but you do not have outcome data.” Another panelist asked why the control arm of Grail’s randomized clinical trial in the UK was not included in the briefing document; the primary outcome of that trial was not included, either. Grail and FDA said that based on the agreement they came to with the FDA. Another panelist asked why so many patients from Grail’s other big study were not included in the briefing material; Grail said that had to do with when the data were submitted. What’s interesting is that the FDA seems to be telling the panel to limit the scope of its discussion. An FDA official said that both follow-ups and outcome data were beyond the scope of the claim being considered.
7
4
18
8,176